Organisation paid for research Program year 2025 Source: CMS Open Payments

Ten20 Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$148,958

3 payments

Through program year 2025, Ten20 Clinical Research is reported as receiving $148,958 in research payments, across 3 payments.

By program year

2 rows
Year Kind Amount Payments
2025 Research $103,027 1
2024 Research $45,931 2

Breakdown

Who paid Research payments · program years 2024–2025
  1. Amgen Inc. $148,958 3 payments
Studies the money was for Research payments · program years 2024–2025
  1. A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma $103,027 1 payment
  2. STARLIGHT P2 LCM Asthma $45,931 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record